ClinicalTrials.Veeva

Menu

Clinical Outcomes of Peroral Endoscopic Myotomy

A

Asan Medical Center

Status

Unknown

Conditions

Achalasia

Treatments

Other: peroral endoscopic myotomy

Study type

Interventional

Funder types

Other

Identifiers

NCT02989883
2016-0999

Details and patient eligibility

About

Esophageal outflow obstruction is characterized by failure to relax the lower esophageal sphincter (LES), resulting in impaired flow of ingested food into the stomach. The subsequent stasis of ingested food leads to symptoms of dysphagia, regurgitation, chest pain, and weight loss. The core objective of the treatment of esophageal outflow obstruction is to disrupt the LES and reduce its pressure to allow esophageal emptying. Therapeutic options include pharmacologic therapy, Botulinum toxin injection, pneumatic balloon dilation, and surgical myotomy with partial fundoplication. In addition, peroral endoscopy myotomy (POEM) has recently been introduced as a minimally invasive treatment, but there have a few studies regarding long-term outcomes. The aim of this study is to evaluate clinical outcomes of POEM for esophageal outflow obstruction.

Full description

Prospective study

Enrollment

20 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who were diagnosed as esophageal outflow obstruction
  • Patients with informed consent

Exclusion criteria

  • Diagnostic uncertainty
  • Patients who are not suitable for general anesthesia

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Peroral endoscopic myotomy (POEM)
Other group
Description:
Patients who received POEM
Treatment:
Other: peroral endoscopic myotomy

Trial contacts and locations

1

Loading...

Central trial contact

Hwoon-Yong Jung

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems